Best Heart And Lungs Transplant Clinics and Prices in Turkey for Australians

Success rates for heart and lung transplants in Turkey align with international benchmarks. This is especially true at high-volume, JCI-accredited centres. Leading cardiac institutions report 1-year heart transplant survival rates between 85% and 92%. Lung transplant 1-year survival typically ranges from 61% to 65% at specialised facilities.

• Heart survival: 1-year survival reaches up to 95% at top-tier adult and paediatric cardiac programs.
• Long-term heart: 5-year survival rates typically range from 70% to 75% with structured follow-up care.
• Lung survival: 3-year survival sits around 51%, while 5-year overall patient survival is roughly 42%.
• Specialised surgeons: Experts like Dr Ertan Emek at Biruni University Hospital perform these complex transplants.
• Infrastructure: Turkey maintains 15 active heart transplant centres and several dedicated lung transplant facilities.

Bookimed Expert Insight: While combined heart-lung transplants cost from $250,000 to $400,000, success depends on hospital-specific volumes. Centres like Memorial Antalya Hospital serve 1.6 million patients annually. Their high case numbers often correlate with more refined post-operative infection control protocols.

Patient Consensus: Patients find that outcomes depend heavily on the surgical team and strict adherence to immunosuppressants. Survival statistics in Turkey are improving as surgical techniques and post-op care continue to advance.

Turkey hosts specialised centres certified for heart and lung transplants. These include Ankara Bilkent City Hospital and Koşuyolu Yüksek İhtisas Research and Training Hospital. These facilities operate under strict Turkish Ministry of Health licensing. They also follow Joint Commission International standards. They perform complex cardiothoracic surgeries.

• Licensed facilities: Ankara Bilkent City Hospital houses a specialised Lung Transplantation Center.
• Public centres: Koşuyolu Research and Training Hospital handles heavy-duty cardiovascular and lung interventions.
• Academic institutions: Marmara University and Ege University are certified for complex thoracic protocols.
• Private infrastructure: Memorial Şişli and Medipol Mega provide JCI-accredited transplant and ICU divisions.
• Specialist surgeons: Dr Ertan Emek at Biruni University Hospital performs heart and lung transplants.

Bookimed Expert Insight: Many private clinics market general surgery. However, heart and lung transplants are restricted to specific tertiary hospitals. Centres like Memorial Antalya are licensed for liver and kidney transplants. However, only a handful of facilities possess the ECMO life-support and hybrid theatres. These are needed for thoracic organs.

Patient Consensus: Patients recommend focusing on large tertiary hospitals for complex cardiac care. These include Acıbadem or Anadolu Medical Center. They suggest verifying official Health Ministry licences in Turkey. This is better than relying on general marketing.

Heart and lung transplants in Turkey involve complex clinical risks. These include acute organ rejection, primary graft dysfunction, and severe infection from heavy immunosuppression. Recovery occurs in stages. It starts with 5–14 days in ICU and requires 3–6 months for mid-term rehabilitation.

• Organ rejection: Highest risk occurs during the first 12 months, requiring lifelong medication.
• ICU monitoring: Patients spend 5–14 days in intensive care for mechanical ventilation.
• Hospital stay: Inpatient ward recovery typically lasts 2–4 weeks for monitoring and biopsies.
• Travel restrictions: Patients must remain in Turkey for 1–3 months for frequent check-ups.
• Physical limits: Heavy lifting and driving are strictly restricted for at least 6–12 weeks.

Bookimed Expert Insight: Turkish centres like Memorial Antalya Hospital hold JCI accreditation. This is vital for transplant safety. Data shows surgeons like Dr. Ertan Emek specialise specifically in multi-organ thoracic transplants. Patients should avoid any provider promising a flight home in under three weeks. This is because rejection monitoring requires locally stable biopsies first.

Patient Consensus: Recovery in Turkey is a slow, staged process. The first year is the most fragile period. Expect to spend months reaching functional levels. Strictly avoid grapefruit or unhygienic foods to protect your new organs.

International patients cannot join the national deceased-donor waiting list in Turkey. This list covers heart and lung transplants. Turkish Ministry of Health regulations prioritise cadaveric organs for citizens and residents. Non-citizens are restricted from the national registry to maintain ethical standards and prevent organ trafficking.

• Deceased-donor priority: National coordination centres allocate thoracic organs strictly to Turkish citizens.
• Legal restrictions: Turkey follows the Declaration of Istanbul to prevent commercial organ trade.
• Ethics commission: Non-residents must undergo mandatory administrative review before any transplant procedure.
• Alternatives: Facilities like Memorial Göztepe Hospital offer mechanical support systems for heart failure.

Bookimed Expert Insight: Deceased-donor lists are closed to international patients. However, surgeons like Dr Ertan Emek at Biruni University Hospital specialise in complex thoracic cases. Patients often travel for mechanical circulatory support, such as LVAD implantation. This procedure does not require a donor. These procedures can cost from $250,000 to $400,000. They offer a vital bridge while awaiting other options.

Patient Consensus: International patients face strict legal reviews in Turkey. These reviews ensure all transplant activities remain ethical. Patients recommend getting written confirmation from hospitals about eligibility. They should do this before planning any travel for cardiac care.